DNA methyltransferases — Drug Target

All drugs that target DNA methyltransferases — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Hypomethylating agent

Phase 2 pipeline (1)

• Azacitidine associated with Valproic acid · Assistance Publique - Hôpitaux de Paris · Hypomethylating agent · Oncology
  Azacitidine is a hypomethylating agent that works by inhibiting DNA methyltransferases, leading to increased expression of tumor suppressor genes.